About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Active Not RecruitingNANCT06487598

To Evaluate add-on Effect of Nisha-Amalaki Tablets Along With Insulin on Glycemic Control in Type 1 Diabetes Patients (RCTNA)

Type-I diabetes mellitus (T1DM) is an autoimmune condition, in which the pancreas reduces/stops insulin production. Patients with T DM have to take insulin injections with every meal and also usually ...

Lead sponsor: Hirabai Cowasji Jehangir Medical Research Institute•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Hirabai Cowasji Jehangir Medical Research Institute

Age

10 - 18 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. K/C/O type-I DM for more than 1 year
•2. Age above 10 years, (10-18 years) irrespective of sex, religion, and economic status
•3. Parents provide consent and children providing assent for the study

Exclusion Criteria

•1. K/C/O type-I DM for more than 1 year
•2. Age above 10 years, (10-18 years) irrespective of sex, religion, and economic status
•3. Parents provide consent and children providing assent for the study

Related studies

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more

Automated Insulin for Management of Intrapartum Glycemia

NCT06883344 · Type 1 Diabetes (T1D), Pregnancy, and more

RECRUITINGPhase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321 · Type 1 Diabetes Mellitus

Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)

NCT07457580 · Type 1 Diabetes

Long-Term Outcomes of Teplizumab in Routine Clinical Care

NCT07360080 · Type 1 Diabetes

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 2, 2024Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhaseNA

Enrollment70

Start dateJul 2024

Last updatedOct 2, 2024

Condition

Type 1 Diabetes

Locations shown

Hirabai Cowasji Jehangir Medical Research Institute

Pune, Maharashtra

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 2, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions